Revance(RVNC) Prnewswire·2025-02-27 10:45Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Revance Therapeutics, Inc. regarding a class action lawsuit due to alleged misleading statements and material breaches related to a Distribution Agreement with Teoxane [1][2]. Group 1: Allegations and Class Period - The class period for the allegations is from February 29, 2024, to December 6, 2024 [1]. - Allegations include that Revance was in material breach of the Distribution Agreement with Teoxane, which granted exclusive rights to import, market, promote, sell, and distribute Teoxane's dermal fillers [1]. - The breach allegedly increased the risk of litigation and monetary and reputational harm to the company [1]. - The allegations suggest that the company's public statements were materially false and misleading during the class period [1]. Group 2: Next Steps for Shareholders - Shareholders are encouraged to register for the class action by March 4, 2025, to potentially be appointed as lead plaintiff [2]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case [2]. - Participation in the case incurs no cost or obligation for the shareholders [2]. Group 3: About the Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit, fraud, and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [3].